• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Murchinson Takes Action to Replace Board of Directors of Nano Dimension at Upcoming Annual General Meeting

    8/3/23 3:00:00 PM ET
    $BWAY
    $INSG
    $MCK
    $NNDM
    Medical/Dental Instruments
    Health Care
    Telecommunications Equipment
    Telecommunications
    Get the next $BWAY alert in real time by email

    Highlights Entrenchment Tactics Taken by the Board Before and Following March Special Meeting Where Shareholders Overwhelmingly Supported Murchinson's Case for Change – Including the Removal of CEO and Chairman Yoav Stern From the Board

    Puts Forward Proposals to Improve Company's Failed Corporate Governance by Seeking to Remove All Current Directors and Appoint Five New, Experienced and Independent Nominees

    Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 5.9% of the outstanding shares of Nano Dimension Ltd., a company incorporated in Israel (NASDAQ:NNDM) ("Nano Dimension" or the "Company"), today announced that it has submitted proposals to the Company for inclusion on the agenda for the upcoming Annual General Meeting of Shareholders (the "Annual Meeting") scheduled for September 7, 2023.

    Exercising its right under Israeli law, Murchinson submitted proposals aimed at overhauling the Company's broken corporate governance, which Murchinson believes is the only pathway to improving Nano Dimension's negative enterprise value and track record of poor financial performance.

    The proposals call for:

    1. The replacement or removal of all members of the Board of Directors (the "Board"), including those who are not up for re-election at the Annual Meeting;
    2. The election or appointment of five new independent and experienced director nominees: Ms. Karen Sarid, Mr. Robert (Bob) Pons, Mr. Phillip Borenstein, Ms. Timor Arbel-Sadras, and Mr. Ofir Baharav; and
    3. Amending the Company's Articles of Association to drastically improve its governance including, among other things, the declassification of the Board.

    Murchinson stated:

    "At the Special Meeting convened by Murchinson on March 20, 2023, Nano Dimension's shareholders sent a clear message that change was urgently needed on the Company's Board. In response, Yoav Stern and Nano Dimension have taken every possible step to ignore the will of shareholders and further entrench themselves. These actions have included wasting shareholder capital by refusing to acknowledge the outcome of the vote, filing frivolous lawsuits against Murchinson and other significant investors, and waging an irrational, dead-end campaign to acquire Stratasys Ltd.

    Given that Nano Dimension has remained resolute in its desire to disenfranchise its own shareholders, we have been forced to put forth proposals to effectively replace the entire Board at the upcoming Annual Meeting. In our view, the only way to reverse the status quo of terrible governance and value destruction is to install independent directors who collectively possess the relevant 3D printing, technology, industry, operating, strategic, financial planning, M&A and governance expertise and experience. We believe that a new Board is urgently needed to protect shareholders' interests and are committed to making this a reality – regardless of any further entrenchment maneuvers taken by Nano Dimension."

    ***

    APPENDIX: MURCHINSON'S DIRECTOR CANDIDATES

    Karen Sarid brings decades of marketing, financial, operational and governance expertise, having served as a public company director and senior-level executive throughout her career.

    • Currently serves as a Director at Brainsway Ltd. (NASDAQ, TASE: BWAY), a healthcare services company, since 2017, where she serves as Chair of the Audit Committee and a member of the Compensation and Executive Committees.
    • Previously served as Vice President of Beauty and Dental and Chairman of China activities at Syneron Medical Ltd. and as President of Alma Lasers Ltd.
    • Previously awarded "CFO of the Year" by The Israeli Forum of Chief Financial Officers, which is a consortium of CFOs from Israeli corporations with annual revenue exceeding 150 million NIS.

    Robert (Bob) Pons has a lengthy track record of creating shareholder value, having served on the boards of directors of more than a dozen publicly traded companies and by bringing his experience as a turnaround specialist after more than four decades as a CEO and senior executive in high growth companies.

    • Served as President and Chief Executive Officer of Spartan Advisors, Inc., a management consulting firm specializing in telecom and technology companies, since 2017.
    • Previously served as Executive Vice President of PTGi-ICS, a wholly owned subsidiary of HC2 Holdings, Inc., a publicly traded holding company operating subsidiaries in infrastructure, telecom, construction, energy technology, gaming and life science.
    • Served on a number of public boards, including as Executive Chairman of Seachange International, Inc. (NASDAQ:SEAC) as well as a director at CCUR Holdings, Inc. (OTCPK: CCUR), Alaska Communications, Inc., Inseego Corp. (NASDAQ:INSG) and MRV Communications, Inc.

    Phillip Borenstein has significant experience creating value at companies drawing on his private equity, M&A, operational and corporate governance expertise as a senior executive and director in addition to his proficiency in financial analysis and asset management.

    • Founded and currently serves as a Partner at Hamilton EQ Management LLC, where he has managed its portfolio of commercial real estate and healthcare facilities since 2016.
    • Serves as a Director, Portfolio Manager, and Partner at Hamilton Equity Partners LLC, a private equity firm, since 2014.
    • Raised the seed money and is an active partner and supporter of the Triumph Leadership Innovation group, an organization working to empower and develop young managers.
    • Earned an M.S. degree in accounting, including research and studies relating to forensic reviews of public company financial reports.

    Timor Arbel-Sadras brings more than two decades of experience in the high-tech sector with a strong track record creating value by driving operational, investment and strategic decisions as a senior leader and director in numerous Israeli companies.

    • Currently serves as Chief Executive Officer of LeumiTech, the leading high-tech banking arm of Israel's largest bank, Bank Leumi Le Israel BM (TASE: LUMI), since 2021.
    • Previously served as a member of the Board of Directors of Negev Group Ltd., and as a board observer of various companies, including ControlUp Technologies Ltd., Earnix Ltd., and Rav Bariach Industries Ltd.
    • Led the investment decisions in Israeli technology and industrial companies while serving in various roles at Viola Credit, and previously served as Chief Operating Officer of EverC, an Israeli fintech startup.

    Ofir Baharav has a more than two-decade career as a seasoned senior executive and public company director in the technology and 3D printing sector with a focus on M&A, operational improvements, corporate governance and enhancing shareholder value.

    • Previously served as Chairman of the Nano Dimension Board from 2019 to 2021, and as a director at the Company from 2015 to 2021.
    • Currently serves as Chief Executive Officer of Maxify Solutions, Inc., since 2022, which he formed to acquire the assets of Breezer Holdings LLC and SimiGon Inc. after serving as SimiGon's CEO since 2016.
    • Served in various executive roles in the 3D printing and semiconductor sector, and was the founder of RelayHealth Corporation, a healthcare company that was acquired by McKesson Corp. (NYSE:MCK).

    ***

    About Murchinson

    Founded in 2012 and based in Toronto, Canada, Murchinson is an alternative asset management firm that serves institutional investors, family offices and qualified clients. The firm has extensive experience capturing the best returning opportunities across global markets. Murchinson's multi-strategy approach allows it to execute investments at all points in the market cycle with fluid allocation between strategies. Our team targets corporate action, distressed investing, private equity and structured finance situations, leveraging its broad market experience with a variety of specialized products and sophisticated hedging techniques to deliver alpha within a risk-averse mandate. Learn more at www.murchinsonltd.com.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward-looking information within the meaning of applicable securities laws. In general, forward-looking information refers to disclosure about future conditions, courses of action, and events. All statements contained in this press release that are not clearly historical in nature or that necessarily depend on future events are forward‐looking, and the use of any of the words "anticipates", "believes", "expects", "intends", "plans", "will", "would", and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations of Murchinson and currently available information. Forward-looking statements are not guarantees of future performance, involve certain risks and uncertainties that are difficult to predict, and are based upon assumptions as to future events that may not prove to be accurate. Murchinson undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

    Disclaimer

    The information contained or referenced herein is for information purposes only in order to provide the views of Murchinson and the matters which Murchinson believes to be of concern to shareholders described herein. The information is not tailored to specific investment objections, the financial situations, suitability, or particular need of any specific person(s) who may receive the information, and should not be taken as advice in considering the merits of any investment decision. The views expressed herein represent the views and opinions of Murchinson, whose opinions may change at any time and which are based on analyses of Murchinson and its advisors.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230802963180/en/

    Get the next $BWAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BWAY
    $INSG
    $MCK
    $NNDM

    CompanyDatePrice TargetRatingAnalyst
    McKesson Corporation
    $MCK
    12/4/2024$630.00Neutral
    Mizuho
    Inseego Corp.
    $INSG
    11/14/2024$13.00 → $15.00Neutral → Buy
    ROTH MKM
    McKesson Corporation
    $MCK
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/5/2024$670.00 → $665.00Outperform
    Leerink Partners
    McKesson Corporation
    $MCK
    8/8/2024$540.00 → $570.00Neutral
    Mizuho
    McKesson Corporation
    $MCK
    2/26/2024$600.00Outperform
    Leerink Partners
    McKesson Corporation
    $MCK
    1/3/2024$537.00Overweight
    Barclays
    More analyst ratings

    $BWAY
    $INSG
    $MCK
    $NNDM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nano Dimension Reports First Quarter 2025 Financial Results

      Core Business Revenue of $14.4 Million, 8% Higher Year-Over-Year Conference Call Today at 4:30 PM EDT WALTHAM, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension" or the "Company"), a leader in Digital Manufacturing solutions, today announced its financial results for the first quarter ended March 31, 2025. The following information does not reflect the results or impact of Desktop Metal, Inc. ("Desktop Metal") or Markforged Holding Corporation ("Markforged") unless stated otherwise, as transactions concerning these companies were completed after the conclusion of the first quarter. First Quarter 2025 Highlights

      6/12/25 4:05:05 PM ET
      $NNDM
      Electrical Products
      Technology
    • McKesson to Host Investor Day on September 23, 2025

      McKesson Corporation (NYSE:MCK) announced it will host an Investor Day on Tuesday, September 23, 2025, in New York City. The event will feature presentations by McKesson's leadership team followed by a Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. Management will provide an update on the company's strategic priorities, growth strategies, and business outlook. A live webcast of the event and replay, along with the company's slide presentation will be available on McKesson's Investor Relations website at investor.mckesson.com, where you can find a complete listing of upcoming events, including details and updates. About McKesson Corporati

      6/11/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Nano Dimension Strengthens Board with Technology and Growth Experts to Accelerate Global Manufacturing Platform Expansion

      Waltham, Massachusetts, June 11, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension" or the "Company"), a leader in Digital Manufacturing solutions, has appointed two technology and growth experts, Andy Sriubas and Eileen Tanghal, to its Board of Directors. The appointments come at a pivotal moment as the Company shifts from M&A integration to scaling a unified technology platform across its global markets. "We are strengthening our board at a critical moment in Nano Dimension's development," said Ofir Baharav, CEO, Nano Dimension. "With our digital manufacturing platform now aligned and abundant opportunities in front of us, Andy and Eileen bring forward-thinkin

      6/11/25 8:00:00 AM ET
      $NNDM
      Electrical Products
      Technology

    $BWAY
    $INSG
    $MCK
    $NNDM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Mizuho resumed coverage on McKesson with a new price target

      Mizuho resumed coverage of McKesson with a rating of Neutral and set a new price target of $630.00

      12/4/24 7:43:38 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Inseego upgraded by ROTH MKM with a new price target

      ROTH MKM upgraded Inseego from Neutral to Buy and set a new price target of $15.00 from $13.00 previously

      11/14/24 7:37:00 AM ET
      $INSG
      Telecommunications Equipment
      Telecommunications
    • McKesson upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded McKesson from Neutral to Outperform and set a new price target of $688.00 from $531.00 previously

      11/7/24 6:29:13 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $BWAY
    $INSG
    $MCK
    $NNDM
    SEC Filings

    See more
    • SEC Form DEFA14A filed by McKesson Corporation

      DEFA14A - MCKESSON CORP (0000927653) (Filer)

      6/20/25 4:26:12 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form DEF 14A filed by McKesson Corporation

      DEF 14A - MCKESSON CORP (0000927653) (Filer)

      6/20/25 4:19:35 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 6-K filed by Nano Dimension Ltd.

      6-K - Nano Dimension Ltd. (0001643303) (Filer)

      6/13/25 10:06:22 AM ET
      $NNDM
      Electrical Products
      Technology

    $BWAY
    $INSG
    $MCK
    $NNDM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $BWAY
    $INSG
    $MCK
    $NNDM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Sarvikas Juho bought $97,800 worth of shares (10,000 units at $9.78), increasing direct ownership by 8% to 134,347 units (SEC Form 4)

      4 - INSEEGO CORP. (0001022652) (Issuer)

      3/5/25 4:05:10 PM ET
      $INSG
      Telecommunications Equipment
      Telecommunications
    • Executive Chairman Brace Philip G bought $124,000 worth of shares (10,000 units at $12.40), increasing direct ownership by 6% to 177,763 units (SEC Form 4)

      4 - INSEEGO CORP. (0001022652) (Issuer)

      11/18/24 7:56:34 AM ET
      $INSG
      Telecommunications Equipment
      Telecommunications
    • Chief Executive Officer Tyler Brian S. gifted 4,000 shares, decreasing direct ownership by 8% to 47,243 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      6/11/25 2:05:11 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Tyler Brian S. sold $13,673,864 worth of shares (19,370 units at $705.93), decreasing direct ownership by 27% to 51,243 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      6/9/25 3:28:44 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • EVP, Chief Strategy & BDO Rodgers Thomas L sold $2,058,912 worth of shares (2,891 units at $712.18), decreasing direct ownership by 53% to 2,544 units (SEC Form 4)

      4 - MCKESSON CORP (0000927653) (Issuer)

      6/2/25 6:40:36 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care